TurboHawk Helps Drive Q4 Peripheral Vascular Sales Growth At ev3

Device maker ev3's peripheral vascular sales advanced 8% to $73.7 million in the fourth quarter, driven by the new TurboHawk plaque excision system

More from Archive

More from Medtech Insight